GleanMark

CTI BIOPHARMA Trademark

CTI BIOPHARMA is a USPTO trademark filed by CTI BIOPHARMA CORP.. Status: Registered.

Trademark Facts

MarkCTI BIOPHARMA
Serial Number86282220
Registration Number5166752
StatusRegistered
Filing Date2014-05-15
Registration Date2017-03-21
Mark TypeWord
Nice Classes005 (Pharmaceuticals), 041 (Education & Entertainment), 042 (Software & IT)
OwnerCTI BIOPHARMA CORP.
Attorney of RecordFrances M. Jagla
Prosecution Events62
Latest EventREM2 on 2026-03-21

Goods & Services

Class 005: Pharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens; Class 041: Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders; Class 042: Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; Pharmaceutical research and development; Providing technical consultation in the field of pharmaceutical product research and development; Medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; Scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; Pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing

Related